Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dorothy Crowfoot Hodgkin made key contributions to Medical Sciences and was the third woman to win the Nobel Prize in Chemistry

Black and white photograph of Dorothy Crowfood Hodgkin

The New Biochemistry Building on South Parks Road has been renamed the Dorothy Crowfoot Hodgkin Building in honour of the third woman to win the Nobel Prize in Chemistry. Dorothy Crowfoot Hodgkin won the 1964 Nobel Prize in Chemistry for solving the atomic structure of molecules such as penicillin and insulin by using X-ray crystallography. The renaming of the building in Dorothy Crowfoot Hodgkin’s honour not only commemorates her ground-breaking research contributions to Medical Sciences; it also serves as a reminder of the vital research that takes place in the building today and celebrates her years-long association with the city of Oxford and the University.

The Dorothy Crowfoot Hodgkin Building is home to the Department of Biochemistry, the Kavli Institute for Nanoscience Discovery, the Oxford Genomics Centre, and a section of the Centre for Medicines Discovery.

Read the full story on the Department of Biochemistry website

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.